SEI Investments’s Antares Pharma, Inc. ATRS Stock Holding History

SEI Investments’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-33,619	Closed	-$131K	–	2666
2021 Q1	$131K	Hold	33,619	–	–	﹤0.01%	2430
2020 Q4	$131K	Sell	33,619 -1,123	-3%	-$3.63K	﹤0.01%	2395
2020 Q3	$88K	Buy	34,742 +208	+0.6%	+$576	﹤0.01%	2345
2020 Q2	$90K	Sell	34,534 -390	-1%	-$1.09K	﹤0.01%	2329
2020 Q1	$80K	Sell	34,924 -114,719	-77%	-$390K	﹤0.01%	2273
2019 Q4	$703K	Buy	+149,643	New	+$612K	﹤0.01%	1785
2019 Q2	–	Sell	-52,439	Closed	-$159K	–	2882
2019 Q1	$159K	Buy	+52,439	New	+$170K	﹤0.01%	2360

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SEI Investments's ATRS Position: Q2 2021 in Review

SEI Investments sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 33,619 shares — an estimated $131K sold.

SEI Investments first reported a position in ATRS in Q1 2019 and held it in 7 quarters. The position peaked at $703K in Q4 2019. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

SEI Investments reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
SEI Investments sold 33,619 Antares Pharma, Inc. shares in Q2 2021, an estimated $131K.
SEI Investments first reported a position in Antares Pharma, Inc. in Q1 2019 and held it in 7 quarters.
SEI Investments's Antares Pharma, Inc. position peaked at $703K in Q4 2019.
175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on SEI Investments's 13F filing for Q2 2021, filed 6 Aug 2021.